Maraviroc Immune Recovery Study, A Multicenter, Randomized, Placebo-Controlled, Exploratory Mechanistic Study Into the Role of Maraviroc on Immune Recovery.
Phase of Trial: Phase IV
Latest Information Update: 26 Feb 2015
At a glance
- Drugs Maraviroc (Primary) ; Antiretrovirals
- Indications HIV infections
- Focus Therapeutic Use
- Acronyms MIRS
- 10 Jun 2017 Biomarkers information updated
- 06 Mar 2013 Primary endpoint 'CD4+-cell-count' has not been met.
- 06 Mar 2013 Results presented at the 20th Conference on Retroviruses and Opportunistic Infections.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History